glp-1 news 48 hours Alarming rise in weight loss drug overdoses GLP-1 Weight-Loss Drug Demonstration Begins

Lancet 406 , 14841496 (2025)

Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients

In vitro stability assay with high glutathione concentration GLP-1MK-801 was dissolved in dimethyl sulfoxide at a concentration of 0.25 mM and diluted with a solution of 200 mM glutathione in PBS, pH 7, such that the final concentration of GLP-1MK-801 in the assay was 100 M

So happy with staff at Pacholec Center for weight Loss

But now scientists are raising concerns that are likely to surprise both patients and physicians: possible bone fractures and even vision problems